Low  ||| S:0 E:4 ||| JJ
tissue  ||| S:4 E:11 ||| NN
oxygen  ||| S:11 E:18 ||| NN
saturation  ||| S:18 E:29 ||| NN
at  ||| S:29 E:32 ||| IN
the  ||| S:32 E:36 ||| DT
end  ||| S:36 E:40 ||| NN
of  ||| S:40 E:43 ||| IN
early  ||| S:43 E:49 ||| JJ
goal-directed  ||| S:49 E:63 ||| JJ
therapy  ||| S:63 E:71 ||| NN
is  ||| S:71 E:74 ||| VBZ
associated  ||| S:74 E:85 ||| VBN
with  ||| S:85 E:90 ||| IN
worse  ||| S:90 E:96 ||| JJR
outcome  ||| S:96 E:104 ||| NN
in  ||| S:104 E:107 ||| IN
critically  ||| S:107 E:118 ||| RB
ill  ||| S:118 E:122 ||| JJ
patients  ||| S:122 E:131 ||| NNS
The  ||| S:131 E:135 ||| DT
prognostic  ||| S:135 E:146 ||| JJ
value  ||| S:146 E:152 ||| NN
of  ||| S:152 E:155 ||| IN
continuous  ||| S:155 E:166 ||| JJ
monitoring  ||| S:166 E:177 ||| NN
of  ||| S:177 E:180 ||| IN
tissue  ||| S:180 E:187 ||| NN
oxygen  ||| S:187 E:194 ||| NN
saturation  ||| S:194 E:205 ||| NNS
( ||| S:205 E:206 ||| -LRB-
StO2 ||| S:206 E:210 ||| NNP
)  ||| S:210 E:212 ||| -RRB-
during  ||| S:212 E:219 ||| IN
early  ||| S:219 E:225 ||| JJ
goal-directed  ||| S:225 E:239 ||| JJ
therapy  ||| S:239 E:247 ||| NN
of  ||| S:247 E:250 ||| IN
critically  ||| S:250 E:261 ||| RB
ill  ||| S:261 E:265 ||| JJ
patients  ||| S:265 E:274 ||| NNS
has  ||| S:274 E:278 ||| VBZ
not  ||| S:278 E:282 ||| RB
been  ||| S:282 E:287 ||| VBN
investigated ||| S:287 E:299 ||| VBN
.  ||| S:299 E:301 ||| .
We  ||| S:301 E:304 ||| PRP
conducted  ||| S:304 E:314 ||| VBD
this  ||| S:314 E:319 ||| DT
prospective  ||| S:319 E:331 ||| JJ
study  ||| S:331 E:337 ||| NN
to  ||| S:337 E:340 ||| TO
test  ||| S:340 E:345 ||| VB
the  ||| S:345 E:349 ||| DT
hypothesis  ||| S:349 E:360 ||| NN
that  ||| S:360 E:365 ||| IN
the  ||| S:365 E:369 ||| DT
persistence  ||| S:369 E:381 ||| NN
of  ||| S:381 E:384 ||| IN
low  ||| S:384 E:388 ||| JJ
StO2  ||| S:388 E:393 ||| CD
levels  ||| S:393 E:400 ||| NNS
following  ||| S:400 E:410 ||| VBG
intensive  ||| S:410 E:420 ||| JJ
care  ||| S:420 E:425 ||| NN
admission  ||| S:425 E:435 ||| NN
is  ||| S:435 E:438 ||| VBZ
related  ||| S:438 E:446 ||| VBN
to  ||| S:446 E:449 ||| TO
adverse  ||| S:449 E:457 ||| JJ
outcome ||| S:457 E:464 ||| NN
.  ||| S:464 E:466 ||| .
We  ||| S:466 E:469 ||| PRP
followed  ||| S:469 E:478 ||| VBD
22  ||| S:478 E:481 ||| CD
critically  ||| S:481 E:492 ||| CD
ill  ||| S:492 E:496 ||| JJ
patients  ||| S:496 E:505 ||| NNS
admitted  ||| S:505 E:514 ||| VBN
with  ||| S:514 E:519 ||| IN
increased  ||| S:519 E:529 ||| JJ
lactate  ||| S:529 E:537 ||| JJ
levels  ||| S:537 E:544 ||| NNS
( ||| S:544 E:545 ||| -LRB-
> ||| S:545 E:546 ||| CD
3  ||| S:546 E:548 ||| CD
mmol ||| S:548 E:552 ||| CD
/ ||| S:552 E:553 ||| CD
l ||| S:553 E:554 ||| CD
) ||| S:554 E:555 ||| -RRB-
.  ||| S:555 E:557 ||| .
Near-infrared  ||| S:557 E:571 ||| JJ
spectroscopy  ||| S:571 E:584 ||| NNS
( ||| S:584 E:585 ||| -LRB-
NIRS ||| S:585 E:589 ||| NNP
)  ||| S:589 E:591 ||| -RRB-
was  ||| S:591 E:595 ||| VBD
used  ||| S:595 E:600 ||| VBN
to  ||| S:600 E:603 ||| TO
measure  ||| S:603 E:611 ||| VB
the  ||| S:611 E:615 ||| DT
thenar  ||| S:615 E:622 ||| JJ
eminence  ||| S:622 E:631 ||| JJ
StO2  ||| S:631 E:636 ||| NN
and  ||| S:636 E:640 ||| CC
the  ||| S:640 E:644 ||| DT
rate  ||| S:644 E:649 ||| NN
of  ||| S:649 E:652 ||| IN
StO2  ||| S:652 E:657 ||| CD
increase  ||| S:657 E:666 ||| NN
( ||| S:666 E:667 ||| -LRB-
RincStO2 ||| S:667 E:675 ||| NNP
)  ||| S:675 E:677 ||| -RRB-
after  ||| S:677 E:683 ||| IN
a  ||| S:683 E:685 ||| DT
vascular  ||| S:685 E:694 ||| JJ
occlusion  ||| S:694 E:704 ||| JJ
test ||| S:704 E:708 ||| NN
.  ||| S:708 E:710 ||| .
NIRS  ||| S:710 E:715 ||| NNP
dynamic  ||| S:715 E:723 ||| JJ
measurements  ||| S:723 E:736 ||| NNS
were  ||| S:736 E:741 ||| VBD
recorded  ||| S:741 E:750 ||| VBN
at  ||| S:750 E:753 ||| IN
intensive  ||| S:753 E:763 ||| JJ
care  ||| S:763 E:768 ||| NN
admission  ||| S:768 E:778 ||| NN
and  ||| S:778 E:782 ||| CC
each  ||| S:782 E:787 ||| DT
2-hour  ||| S:787 E:794 ||| JJ
interval  ||| S:794 E:803 ||| NN
during  ||| S:803 E:810 ||| IN
8  ||| S:810 E:812 ||| CD
hours  ||| S:812 E:818 ||| NNS
of  ||| S:818 E:821 ||| IN
resuscitation ||| S:821 E:834 ||| NN
.  ||| S:834 E:836 ||| .
All  ||| S:836 E:840 ||| DT
repeated  ||| S:840 E:849 ||| VBN
StO2  ||| S:849 E:854 ||| CD
measurements  ||| S:854 E:867 ||| NNS
were  ||| S:867 E:872 ||| VBD
further  ||| S:872 E:880 ||| RB
compared  ||| S:880 E:889 ||| VBN
with  ||| S:889 E:894 ||| IN
Sequential  ||| S:894 E:905 ||| NNP
Organ  ||| S:905 E:911 ||| NNP
Failure  ||| S:911 E:919 ||| NNP
Assessment  ||| S:919 E:930 ||| NNP
( ||| S:930 E:931 ||| -LRB-
SOFA ||| S:931 E:935 ||| NNP
) ||| S:935 E:936 ||| -RRB-
,  ||| S:936 E:938 ||| ,
Acute  ||| S:938 E:944 ||| NNP
Physiology  ||| S:944 E:955 ||| NNP
and  ||| S:955 E:959 ||| CC
Chronic  ||| S:959 E:967 ||| NNP
Health  ||| S:967 E:974 ||| NNP
Evaluation  ||| S:974 E:985 ||| NNP
( ||| S:985 E:986 ||| -LRB-
APACHE ||| S:986 E:992 ||| NNP
)  ||| S:992 E:994 ||| -RRB-
II  ||| S:994 E:997 ||| NNP
and  ||| S:997 E:1001 ||| CC
hemodynamic  ||| S:1001 E:1013 ||| JJ
physiological  ||| S:1013 E:1027 ||| JJ
variables ||| S:1027 E:1036 ||| NNS
:  ||| S:1036 E:1038 ||| :
heart  ||| S:1038 E:1044 ||| NN
rate  ||| S:1044 E:1049 ||| NN
( ||| S:1049 E:1050 ||| -LRB-
HR ||| S:1050 E:1052 ||| NNP
) ||| S:1052 E:1053 ||| -RRB-
,  ||| S:1053 E:1055 ||| ,
mean  ||| S:1055 E:1060 ||| VBP
arterial  ||| S:1060 E:1069 ||| JJ
pressure  ||| S:1069 E:1078 ||| NN
( ||| S:1078 E:1079 ||| -LRB-
MAP ||| S:1079 E:1082 ||| NNP
) ||| S:1082 E:1083 ||| -RRB-
,  ||| S:1083 E:1085 ||| ,
central  ||| S:1085 E:1093 ||| JJ
venous  ||| S:1093 E:1100 ||| JJ
oxygen  ||| S:1100 E:1107 ||| NN
saturation  ||| S:1107 E:1118 ||| NNS
( ||| S:1118 E:1119 ||| -LRB-
ScvO2 ||| S:1119 E:1124 ||| NNP
)  ||| S:1124 E:1126 ||| -RRB-
and  ||| S:1126 E:1130 ||| CC
parameters  ||| S:1130 E:1141 ||| NNS
of  ||| S:1141 E:1144 ||| IN
peripheral  ||| S:1144 E:1155 ||| JJ
circulation  ||| S:1155 E:1167 ||| NN
( ||| S:1167 E:1168 ||| -LRB-
physical  ||| S:1168 E:1177 ||| JJ
examination  ||| S:1177 E:1189 ||| NN
and  ||| S:1189 E:1193 ||| CC
peripheral  ||| S:1193 E:1204 ||| JJ
flow  ||| S:1204 E:1209 ||| NN
index  ||| S:1209 E:1215 ||| NN
( ||| S:1215 E:1216 ||| -LRB-
PFI ||| S:1216 E:1219 ||| NNP
) ||| S:1219 E:1220 ||| -RRB-
) ||| S:1220 E:1221 ||| -RRB-
.  ||| S:1221 E:1223 ||| .
Twelve  ||| S:1223 E:1230 ||| CD
patients  ||| S:1230 E:1239 ||| NNS
were  ||| S:1239 E:1244 ||| VBD
admitted  ||| S:1244 E:1253 ||| VBN
with  ||| S:1253 E:1258 ||| IN
low  ||| S:1258 E:1262 ||| JJ
StO2  ||| S:1262 E:1267 ||| CD
levels  ||| S:1267 E:1274 ||| NNS
( ||| S:1274 E:1275 ||| -LRB-
StO2  ||| S:1275 E:1280 ||| CD
< ||| S:1280 E:1281 ||| SYM
70 ||| S:1281 E:1283 ||| CD
% ||| S:1283 E:1284 ||| NN
) ||| S:1284 E:1285 ||| -RRB-
.  ||| S:1285 E:1287 ||| .
The  ||| S:1287 E:1291 ||| DT
mean  ||| S:1291 E:1296 ||| JJ
scores  ||| S:1296 E:1303 ||| NNS
for  ||| S:1303 E:1307 ||| IN
SOFA  ||| S:1307 E:1312 ||| NNP
and  ||| S:1312 E:1316 ||| CC
APACHE  ||| S:1316 E:1323 ||| NNP
II  ||| S:1323 E:1326 ||| NNP
scores  ||| S:1326 E:1333 ||| NNS
were  ||| S:1333 E:1338 ||| VBD
significantly  ||| S:1338 E:1352 ||| RB
higher  ||| S:1352 E:1359 ||| JJR
in  ||| S:1359 E:1362 ||| IN
patients  ||| S:1362 E:1371 ||| NNS
who  ||| S:1371 E:1375 ||| WP
persisted  ||| S:1375 E:1385 ||| VBD
with  ||| S:1385 E:1390 ||| IN
low  ||| S:1390 E:1394 ||| JJ
StO2  ||| S:1394 E:1399 ||| CD
levels  ||| S:1399 E:1406 ||| NNS
( ||| S:1406 E:1407 ||| -LRB-
n  ||| S:1407 E:1409 ||| CD
=  ||| S:1409 E:1411 ||| SYM
10 ||| S:1411 E:1413 ||| CD
)  ||| S:1413 E:1415 ||| -RRB-
than  ||| S:1415 E:1420 ||| IN
in  ||| S:1420 E:1423 ||| IN
those  ||| S:1423 E:1429 ||| DT
who  ||| S:1429 E:1433 ||| WP
exhibited  ||| S:1433 E:1443 ||| VBP
normal  ||| S:1443 E:1450 ||| JJ
StO2  ||| S:1450 E:1455 ||| CD
levels  ||| S:1455 E:1462 ||| NNS
( ||| S:1462 E:1463 ||| -LRB-
n  ||| S:1463 E:1465 ||| CD
=  ||| S:1465 E:1467 ||| SYM
12 ||| S:1467 E:1469 ||| CD
)  ||| S:1469 E:1471 ||| -RRB-
at  ||| S:1471 E:1474 ||| IN
8  ||| S:1474 E:1476 ||| CD
hours  ||| S:1476 E:1482 ||| NNS
after  ||| S:1482 E:1488 ||| IN
the  ||| S:1488 E:1492 ||| DT
resuscitation  ||| S:1492 E:1506 ||| JJ
period  ||| S:1506 E:1513 ||| NN
( ||| S:1513 E:1514 ||| -LRB-
P  ||| S:1514 E:1516 ||| NNP
< ||| S:1516 E:1518 ||| SYM
0.05 ||| S:1518 E:1522 ||| CD
;  ||| S:1522 E:1524 ||| :
median  ||| S:1524 E:1531 ||| JJ
( ||| S:1531 E:1532 ||| -LRB-
interquartile  ||| S:1532 E:1546 ||| JJ
range ||| S:1546 E:1551 ||| NN
) ||| S:1551 E:1552 ||| -RRB-
:  ||| S:1552 E:1554 ||| :
SOFA ||| S:1554 E:1558 ||| NNP
,  ||| S:1558 E:1560 ||| ,
8  ||| S:1560 E:1562 ||| CD
( ||| S:1562 E:1563 ||| -LRB-
7  ||| S:1563 E:1565 ||| CD
to  ||| S:1565 E:1568 ||| TO
11 ||| S:1568 E:1570 ||| CD
)  ||| S:1570 E:1572 ||| -RRB-
vs.  ||| S:1572 E:1576 ||| IN
5  ||| S:1576 E:1578 ||| CD
( ||| S:1578 E:1579 ||| -LRB-
3  ||| S:1579 E:1581 ||| CD
to  ||| S:1581 E:1584 ||| TO
8 ||| S:1584 E:1585 ||| CD
) ||| S:1585 E:1586 ||| -RRB-
;  ||| S:1586 E:1588 ||| :
APACHE  ||| S:1588 E:1595 ||| NNP
II ||| S:1595 E:1597 ||| NNP
,  ||| S:1597 E:1599 ||| ,
32 ||| S:1599 E:1601 ||| CD
( ||| S:1601 E:1602 ||| -LRB-
24  ||| S:1602 E:1605 ||| CD
to  ||| S:1605 E:1608 ||| TO
33 ||| S:1608 E:1610 ||| CD
)  ||| S:1610 E:1612 ||| -RRB-
vs.  ||| S:1612 E:1616 ||| IN
19  ||| S:1616 E:1619 ||| CD
( ||| S:1619 E:1620 ||| -LRB-
15  ||| S:1620 E:1623 ||| CD
to  ||| S:1623 E:1626 ||| TO
25 ||| S:1626 E:1628 ||| CD
) ||| S:1628 E:1629 ||| -RRB-
) ||| S:1629 E:1630 ||| -RRB-
.  ||| S:1630 E:1632 ||| .
There  ||| S:1632 E:1638 ||| EX
was  ||| S:1638 E:1642 ||| VBD
no  ||| S:1642 E:1645 ||| DT
significant  ||| S:1645 E:1657 ||| JJ
relationship  ||| S:1657 E:1670 ||| NN
between  ||| S:1670 E:1678 ||| IN
StO2  ||| S:1678 E:1683 ||| NNP
and  ||| S:1683 E:1687 ||| CC
mean  ||| S:1687 E:1692 ||| VB
global  ||| S:1692 E:1699 ||| JJ
hemodynamic  ||| S:1699 E:1711 ||| JJ
variables  ||| S:1711 E:1721 ||| NNS
( ||| S:1721 E:1722 ||| -LRB-
HR ||| S:1722 E:1724 ||| NNP
,  ||| S:1724 E:1726 ||| ,
P  ||| S:1726 E:1728 ||| NN
=  ||| S:1728 E:1730 ||| SYM
0.26 ||| S:1730 E:1734 ||| CD
;  ||| S:1734 E:1736 ||| :
MAP ||| S:1736 E:1739 ||| NNP
,  ||| S:1739 E:1741 ||| ,
P  ||| S:1741 E:1743 ||| NN
=  ||| S:1743 E:1745 ||| SYM
0.51 ||| S:1745 E:1749 ||| CD
;  ||| S:1749 E:1751 ||| :
ScvO2 ||| S:1751 E:1756 ||| CD
,  ||| S:1756 E:1758 ||| ,
P  ||| S:1758 E:1760 ||| NN
=  ||| S:1760 E:1762 ||| SYM
0.11 ||| S:1762 E:1766 ||| CD
) ||| S:1766 E:1767 ||| -RRB-
.  ||| S:1767 E:1769 ||| .
However ||| S:1769 E:1776 ||| RB
,  ||| S:1776 E:1778 ||| ,
there  ||| S:1778 E:1784 ||| EX
was  ||| S:1784 E:1788 ||| VBD
a  ||| S:1788 E:1790 ||| DT
strong  ||| S:1790 E:1797 ||| JJ
association  ||| S:1797 E:1809 ||| NN
between  ||| S:1809 E:1817 ||| IN
StO2  ||| S:1817 E:1822 ||| CD
with  ||| S:1822 E:1827 ||| IN
clinical  ||| S:1827 E:1836 ||| JJ
abnormalities  ||| S:1836 E:1850 ||| NN
of  ||| S:1850 E:1853 ||| IN
peripheral  ||| S:1853 E:1864 ||| JJ
perfusion  ||| S:1864 E:1874 ||| NNS
( ||| S:1874 E:1875 ||| -LRB-
P  ||| S:1875 E:1877 ||| NN
=  ||| S:1877 E:1879 ||| SYM
0.004 ||| S:1879 E:1884 ||| CD
) ||| S:1884 E:1885 ||| -RRB-
,  ||| S:1885 E:1887 ||| ,
PFI  ||| S:1887 E:1891 ||| NNP
( ||| S:1891 E:1892 ||| -LRB-
P  ||| S:1892 E:1894 ||| NN
=  ||| S:1894 E:1896 ||| SYM
0.005 ||| S:1896 E:1901 ||| CD
)  ||| S:1901 E:1903 ||| -RRB-
and  ||| S:1903 E:1907 ||| CC
RincStO2  ||| S:1907 E:1916 ||| NNP
( ||| S:1916 E:1917 ||| -LRB-
P  ||| S:1917 E:1919 ||| NN
=  ||| S:1919 E:1921 ||| SYM
0.002 ||| S:1921 E:1926 ||| CD
) ||| S:1926 E:1927 ||| -RRB-
.  ||| S:1927 E:1929 ||| .
The  ||| S:1929 E:1933 ||| DT
persistence  ||| S:1933 E:1945 ||| NN
of  ||| S:1945 E:1948 ||| IN
low  ||| S:1948 E:1952 ||| JJ
StO2  ||| S:1952 E:1957 ||| CD
values  ||| S:1957 E:1964 ||| NNS
was  ||| S:1964 E:1968 ||| VBD
associated  ||| S:1968 E:1979 ||| VBN
with  ||| S:1979 E:1984 ||| IN
a  ||| S:1984 E:1986 ||| DT
low  ||| S:1986 E:1990 ||| JJ
percentage  ||| S:1990 E:2001 ||| NN
of  ||| S:2001 E:2004 ||| IN
lactate  ||| S:2004 E:2012 ||| JJ
decrease  ||| S:2012 E:2021 ||| NN
( ||| S:2021 E:2022 ||| -LRB-
P  ||| S:2022 E:2024 ||| NNP
< ||| S:2024 E:2026 ||| SYM
0.05 ||| S:2026 E:2030 ||| CD
;  ||| S:2030 E:2032 ||| :
median  ||| S:2032 E:2039 ||| JJ
( ||| S:2039 E:2040 ||| -LRB-
interquartile  ||| S:2040 E:2054 ||| JJ
range ||| S:2054 E:2059 ||| NN
) ||| S:2059 E:2060 ||| -RRB-
:  ||| S:2060 E:2062 ||| :
33 ||| S:2062 E:2064 ||| CD
%  ||| S:2064 E:2066 ||| NN
( ||| S:2066 E:2067 ||| -LRB-
12  ||| S:2067 E:2070 ||| CD
to  ||| S:2070 E:2073 ||| TO
43 ||| S:2073 E:2075 ||| CD
% ||| S:2075 E:2076 ||| NN
)  ||| S:2076 E:2078 ||| -RRB-
vs.  ||| S:2078 E:2082 ||| IN
43 ||| S:2082 E:2084 ||| CD
%  ||| S:2084 E:2086 ||| NN
( ||| S:2086 E:2087 ||| -LRB-
30  ||| S:2087 E:2090 ||| CD
to  ||| S:2090 E:2093 ||| TO
54 ||| S:2093 E:2095 ||| CD
% ||| S:2095 E:2096 ||| NN
) ||| S:2096 E:2097 ||| -RRB-
) ||| S:2097 E:2098 ||| -RRB-
.  ||| S:2098 E:2100 ||| .
We  ||| S:2100 E:2103 ||| PRP
found  ||| S:2103 E:2109 ||| VBD
that  ||| S:2109 E:2114 ||| IN
patients  ||| S:2114 E:2123 ||| NNS
who  ||| S:2123 E:2127 ||| WP
consistently  ||| S:2127 E:2140 ||| RB
exhibited  ||| S:2140 E:2150 ||| VBN
low  ||| S:2150 E:2154 ||| JJ
StO2  ||| S:2154 E:2159 ||| CD
levels  ||| S:2159 E:2166 ||| NNS
following  ||| S:2166 E:2176 ||| VBG
an  ||| S:2176 E:2179 ||| DT
initial  ||| S:2179 E:2187 ||| JJ
resuscitation  ||| S:2187 E:2201 ||| NN
had  ||| S:2201 E:2205 ||| VBD
significantly  ||| S:2205 E:2219 ||| RB
worse  ||| S:2219 E:2225 ||| JJR
organ  ||| S:2225 E:2231 ||| NN
failure  ||| S:2231 E:2239 ||| NN
than  ||| S:2239 E:2244 ||| IN
did  ||| S:2244 E:2248 ||| VBD
patients  ||| S:2248 E:2257 ||| NNS
with  ||| S:2257 E:2262 ||| IN
normal  ||| S:2262 E:2269 ||| JJ
StO2  ||| S:2269 E:2274 ||| CD
values ||| S:2274 E:2280 ||| NNS
,  ||| S:2280 E:2282 ||| ,
and  ||| S:2282 E:2286 ||| CC
found  ||| S:2286 E:2292 ||| VBD
that  ||| S:2292 E:2297 ||| IN
StO2  ||| S:2297 E:2302 ||| CD
changes  ||| S:2302 E:2310 ||| NNS
had  ||| S:2310 E:2314 ||| VBD
no  ||| S:2314 E:2317 ||| DT
relationship  ||| S:2317 E:2330 ||| NN
with  ||| S:2330 E:2335 ||| IN
global  ||| S:2335 E:2342 ||| JJ
hemodynamic  ||| S:2342 E:2354 ||| JJ
variables ||| S:2354 E:2363 ||| NNS
.  ||| S:2363 E:2365 ||| .
